Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea

Secretory diarrhea remains a global health burden and causes major mortality in children. There have been some focuses on antidiarrheal therapies that may reduce fluid losses and intestinal motility in diarrheal diseases. In the present study, we identified shikonin as an inhibitor of TMEM16A chlori...

Full description

Bibliographic Details
Main Authors: Yu Jiang, Bo Yu, Hong Yang, Tonghui Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00270/full
_version_ 1811289043434995712
author Yu Jiang
Bo Yu
Hong Yang
Tonghui Ma
author_facet Yu Jiang
Bo Yu
Hong Yang
Tonghui Ma
author_sort Yu Jiang
collection DOAJ
description Secretory diarrhea remains a global health burden and causes major mortality in children. There have been some focuses on antidiarrheal therapies that may reduce fluid losses and intestinal motility in diarrheal diseases. In the present study, we identified shikonin as an inhibitor of TMEM16A chloride channel activity using cell-based fluorescent-quenching assay. The IC50 value of shikonin was 6.5 μM. Short-circuit current measurements demonstrated that shikonin inhibited Eact-induced Cl current in a dose-dependent manner, with IC50 value of 1.5 μM. Short-circuit current measurement showed that shikonin exhibited inhibitory effect against CCh-induced Cl currents in mouse colonic epithelia but did not affect cytoplasmic Ca2+ concentration as well as the other major enterocyte chloride channel CFTR. Characterization study found that shikonin inhibited basolateral K+ channel activity without affecting Na+/K+-ATPase activities. In-vivo studies revealed that shikonin significantly delayed intestinal motility in mice and reduced stool water content in a neonatal mice model of rotaviral diarrhea without affecting the viral infection process in-vivo. Taken together, the results suggested that shikonin inhibited enterocyte CaCCs, the inhibitory effect was partially through inhbition of basolateral K+ channel acitivty, and shikonin could be a lead compound in the treatment of rotaviral secretory diarrhea.
first_indexed 2024-04-13T03:46:52Z
format Article
id doaj.art-645712fb604b41cfbec56654b2301e97
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T03:46:52Z
publishDate 2016-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-645712fb604b41cfbec56654b2301e972022-12-22T03:03:58ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122016-08-01710.3389/fphar.2016.00270211157Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrheaYu Jiang0Bo Yu1Hong Yang2Tonghui Ma3Liaoning normal universityLiaoning normal universityLiaoning normal universityDalian Medical UniversitySecretory diarrhea remains a global health burden and causes major mortality in children. There have been some focuses on antidiarrheal therapies that may reduce fluid losses and intestinal motility in diarrheal diseases. In the present study, we identified shikonin as an inhibitor of TMEM16A chloride channel activity using cell-based fluorescent-quenching assay. The IC50 value of shikonin was 6.5 μM. Short-circuit current measurements demonstrated that shikonin inhibited Eact-induced Cl current in a dose-dependent manner, with IC50 value of 1.5 μM. Short-circuit current measurement showed that shikonin exhibited inhibitory effect against CCh-induced Cl currents in mouse colonic epithelia but did not affect cytoplasmic Ca2+ concentration as well as the other major enterocyte chloride channel CFTR. Characterization study found that shikonin inhibited basolateral K+ channel activity without affecting Na+/K+-ATPase activities. In-vivo studies revealed that shikonin significantly delayed intestinal motility in mice and reduced stool water content in a neonatal mice model of rotaviral diarrhea without affecting the viral infection process in-vivo. Taken together, the results suggested that shikonin inhibited enterocyte CaCCs, the inhibitory effect was partially through inhbition of basolateral K+ channel acitivty, and shikonin could be a lead compound in the treatment of rotaviral secretory diarrhea.http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00270/fullCaCCinhibitorshort-circuit currentTMEM16AShikoninRotaviral diarrhea
spellingShingle Yu Jiang
Bo Yu
Hong Yang
Tonghui Ma
Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea
Frontiers in Pharmacology
CaCC
inhibitor
short-circuit current
TMEM16A
Shikonin
Rotaviral diarrhea
title Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea
title_full Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea
title_fullStr Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea
title_full_unstemmed Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea
title_short Shikonin inhibits intestinal calcium-activated chloride channels and prevents rotaviral diarrhea
title_sort shikonin inhibits intestinal calcium activated chloride channels and prevents rotaviral diarrhea
topic CaCC
inhibitor
short-circuit current
TMEM16A
Shikonin
Rotaviral diarrhea
url http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00270/full
work_keys_str_mv AT yujiang shikonininhibitsintestinalcalciumactivatedchloridechannelsandpreventsrotaviraldiarrhea
AT boyu shikonininhibitsintestinalcalciumactivatedchloridechannelsandpreventsrotaviraldiarrhea
AT hongyang shikonininhibitsintestinalcalciumactivatedchloridechannelsandpreventsrotaviraldiarrhea
AT tonghuima shikonininhibitsintestinalcalciumactivatedchloridechannelsandpreventsrotaviraldiarrhea